A programme of twenty Industry Sponsored Symposia will be available to all participants at the EACR 2025 Congress. This page provides links for the companies taking part as well as their talk titles and when/where you can join them in Lisbon.
biomodal | Monday 16 June, 12:15-13:00 (Auditorium VI+VII)
Part 1: Introduction
Tom Charlesworth, United Kingdom
Part 1: 'Unlocking Hidden Signals: A multimodal approach to ctDNA detection in early prostate cancer'
Hanieh Sadeghi, Austria
Part 2: 'Characterisation of Advanced BC Subtypes in cfDNA by methylation profiling'
Ros Cutts, United Kingdom
Visit biomodal reps at stand 50.
Bruker Spatial Biology | Monday 16 June, 12:15-13:00 (Auditorium VIII)
'Expanding the Limits of Biology: Comprehensive Integrated Technologies for Multiomics in Oncology'
Part 1: Introduction
Kevin Sheehy, United States
Part 2: 'Industry-Leading Spatial Solutions for High-Plex Multiomic Tissue Exploration and Discovery'
Christoph Koenig, Germany
Part 3: 'Streamlining Next-Gen Spatial Proteomics with EpicIF™ Technology and the PowerOMX™ Engine'
Oliver Braubach, United States
Part 4: 'Sub-cellular, multiomic imaging of the entire protein-coding transcriptome (18936-plex RNA) and 75-plex Protein on a single-slide FFPE tissue section using CosMx Spatial Molecular Imaging'
Johnny Lyssand, United States
Visit Bruker Spatial Biology reps at stand 54.
10x Genomics | Monday 16 June, 13:15-14:00 (Auditorium VI+VII)
'See Biology in new Ways - Single Cell and Spatial Transcriptomic Methods to Understand Cancer'
Part 1: Introduction
Claudia May, United States
Part 2: 'Spatial immune landscape of cutaneous squamous cell carcinomas (cSCC) prior to immune checkpoint blockade'
Robin Reschke, Germany
Part 3: 'Improving Immunotherapy Strategies Through Single-Cell Profiling of Lung Cancer'
Philip Bischof, Germany
Visit 10x Genomics reps at stand 25.
Standard BioTools | Monday 16 June, 13:15-14:00 (Auditorium VIII)
'Spatial Predictors of Immunotherapy Response in Triple-Negative Breast Cancer'
Part 1: Introduction
Roberto Spada
Part 2: 'Spatial Predictors of Immunotherapy Response in Triple-Negative Breast Cancer'
Bianchini Giampaolo, Italy
Visit Standard BioTools reps at stand 23.
Thermo Fisher Scientific | Tuesday 17 June, 08:30-09:15 (Auditorium II)
'Advancing Cancer Research through Innovations in Spatial Proteomics and Imaging Technologies'
Part 1: 'Introduction to the Invitrogen™ EVOS™ S1000 Spatial Imaging System'
Francesca Grespi
Part 2: 'Spatial Proteomics: Transforming Our Understanding of Cancer Biology'
Charlotte Stadler, Sweden
Part 3: 'Navigating Challenges in Spatial Proteomics from an Imaging Core facility perspective'
Carolina Oses
Part 4: Q&A
Visit Thermo Fisher Scientific reps at stand 21.
Bruker Cellular Analysis | Tuesday 17 June, 08:30-09:15 (Auditorium VI+VII)
'Experience Live Single-Cell Functional Insights with Beacon Discovery for Oncology & Immunotherapy Research'
Tiago Santos, United States and Yan Zhang, United States
Visit Bruker Cellular Analysis reps at stand 72.
Illumina | Tuesday 17 June, 13:30-14:15 (Auditorium II)
'Empowering discoveries across omics'
Part 1: 'Introduction to multiomics'
Anna Babayan, Germany
Part 2: 'Rapid WGS with Constellation read map technology for paediatric cancer research'
Aditi Vedi, United Kingdom
Part 3: 'Identification of biomarkers for early detection of colorectal cancer: multiomic, epigenetic and metagenomic analysis of rectal mucus sampling'
Daniel Wise, United Kingdom
Part 4: 'BreakThrough Spotlight – Early Career Researcher Unravelling Tumour Genetics: The Role of cfDNA Whole-Exome Sequencing in Treatment Response Assessment'
Viola Bianca Serio, Italy
Part 5: Q&A and panel discussion
Visit Illumina reps at stand 10.
Miltenyi Biotec | Tuesday 17 June, 13:30-14:15 (Auditorium VI+VII)
'Spatial biology for studying tumor microenvironment: paving the way for immunotherapy approaches'
Part 1: 'Characterization of a novel cancer-associated fibroblast population with immunosuppressive functions'
Alina Wittwer, Germany
Part 2: 'Multiplexed Imaging-Powered Deep Visual Proteomics (mipDVP)'
Xiang Zheng, Denmark
Part 3: Q&A
Visit Miltenyi reps at stand 70.
Bio-Rad Laboratories | Tuesday 17 June, 13:30-14:15 (Auditorium VIII)
'Innovating Cancer Science with ddPCR'
Part 1: Introduction
Marco Bianchi, Italy
Part 2: 'Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer'
Laura Muinelo Romay, Spain
Part 3: 'Detection rate for ESR1 mutations is higher in CTC-derived genomic DNA than in paired plasma cell-free DNA samples as revealed by ddPCR'
Aliki Ntzifa, Greece
Part 4: Q&A
Visit Bio-Rad reps at stand 33.
Lunaphore | Tuesday 17 June, 14:30-15:15 (Auditorium II)
'Advancing oncology research with spatial biology'
Part 1: 'One platform and endless possibilities for immuno-oncology research'
Joanna Kowal, Switzerland
Part 2: 'Exploring the Spatial Biology of Colorectal Cancer Liver Metastases'
Ficht Xenia Maria, Switzerland
Visit Lunaphore reps at stand 26.
PromoCell | Tuesday 17 June, 14:30-15:15 (Auditorium VI+VII)
'A toolbox for cancer stem cell selection'
Part 1: Introduction
Lisa-Mareike Scheid, Germany
Part 2: 'How to kill your fibroblasts and save the cancer stem cells in your culture'
Alexander Trampe, Germany
Part 3: 'PromoCell’s Cancer Media Toolbox'
Alexander Trampe, Germany
Part 4: Q&A
Visit PromoCell reps at stand 85.
Element Biosciences | Tuesday 17 June, 14:30-15:15 (Auditorium VIII)
'Leveraging high dimensional multiomic screens with AVITI24™ to accelerate drug discovery'
'Leveraging high dimensional multiomic screens with AVITI24™ to accelerate drug discovery'
Ivonne Nel, Germany
Visit Element Biosciences reps at stand 67.
EditCo Bio | Wednesday 18 June, 08:30-09:15 (Auditorium II)
Introduction: Travis Hardcastle, United States
Part 1: 'Unveiling SURF2’s Role in Nucleolar Stress and Its Potential as a Therapeutic Target'
Simon Lebaron, France
Part 2: 'AI-driven identification and validation of novel synthetic lethal gene pairs'
Daniel Miller, United Kingdom
Part 3: 'Leveraging an advanced CRISPR platform to streamline oncology breakthroughs'
Amalia Soenens
Visit EditCo Bio reps at stand 107.
Arima Genomics | Wednesday 18 June, 08:30-09:15 (Auditorium VI+VII)
'Transposable elements reorganise the 3D genome structure in CDK4/6 inhibitors resistant breast cancer'
Joanna Achinger-Kawecka, Australia
Visit Arima Genomics reps at stand 36.
Akoya Biosciences | Wednesday 18 June, 13:30-14:15 (Auditorium II)
'Scaling Immuno-Oncology Research with IO60: The Fastest UltraHigh-Plex Spatial Proteomics Panel'
Sessions TBC
Ivan Masetto, Kelly Hunter, United Kingdom, and Stéphanie Tissot, Switzerland
Visit Akoya reps at stand 5.
Illumina | Wednesday 18 June, 13:30-14:15 (Auditorium VI+VII)
'Unlocking the Power of Single-Cell and Spatial Multiomics'
Part 1: 'Introducing Illumina Single Cell and Spatial Technology'
Vivek Kumar Mishra, Germany
Part 2: 'Scalable single-cell RNA profiling of pooled CRISPR screens discloses novel biology of cancer and T cells'
Paulien Van Minsel, Belgium
Part 3: 'Cell Altasing Human Intestine using Illumina Spatial Technology'
Chenchen Zhu, United States
Part 4: 'Illumina Connected Multiomics'
Joachim Scmid, Germany
Visit Illumina reps at stand 10.
QIAGEN | Wednesday 18 June, 13:30-14:15 (Auditorium VIII)
'TCR Repertoires of Tumor-Infiltrating γδ1 T Cells Reveal PD-1-Modulated Reactivity'
'TCR Repertoires of Tumor-Infiltrating γδ1 T Cells Reveal PD-1-Modulated Reactivity'
Joanna Mikulak, Italy
Visit QIAGEN reps at stand 37.
Olink | Wednesday 18 June, 14:30-15:15 (Auditorium II)
'Plasma Proteomics: Driving a New Era for Cancer Research and Precision Medicine'
Part 1: 'Olink Proteomics: Accelerating progress in cancer research and the path to therapeutics'
Marijana Guyonnet Rucevic, Sweden
Part 2: 'Deep plasma proteomics identifies and validates an eight-protein biomarker panel for ovarian cancer'
Stefan Enroth, Sweden
Part 3: 'Liquid biopsy: Plasma proteomics to identify novel biomarkers'
Antoine Italiano (France)
Part 4: Q&A
Visit Olink reps at stand 89.
NVision Imaging Technologies | Wednesday 18 June, 14:30-15:15 (Auditorium VI+VII)
'Hyperpolarized MRI agents: Visualize Cancer Metabolism - As It Happens'
Part 1: 'Introduction to C13 Hyperpolarization'
Simon Bennett, Germany
Part 2: 'Applications for imaging and measuring metabolism in vivo'
Simon Bennett, Germany
Part 3: Q&A
Visit NVision reps at stand 112.
Oxford Nanopore Technologies | Wednesday 18 June, 14:30-15:15 (Auditorium VIII)
'Deciphering Cancer Evolution and Progression with Multiomic Single Cell Insights'
Part 1: 'Unlocking Novel Cancer Biology with Multiomic Insights'
Eleonora Juarez, United States
Part 2: 'Bridging genotype and phenotype through single-cell and single-molecule multi-omics'
Luuk Harbers, Belgium
Part 3: 'Tumour heterogeneity and clonal selection of ecDNA at single-cell level'
Josephine Deleuran Hendriksen, Denmark
Visit Oxford Nanopore Technologies reps at stand 106.
Auditorium II |
Auditorium VI+VII |
Auditorium VIII |
Biomodal |
Bruker Spatial Biology |
|
10x Genomics Mon | 13:15-14:00 |
Standard BioTools |
|
Thermo Fisher Scientific Tue | 08:30-09:15 |
Bruker Cellular Analysis Tue | 08:30-09:15 |
|
Illumina Tue | 13:30-14:15 |
Miltenyi Biotec Tue | 13:30-14:15 |
Bio-Rad Laboratories |
Lunaphore |
PromoCell Tue | 14:30-15:15 |
Element Biosciences |
EditCo Bio |
Arima Genomics Wed | 08:30-09:15 |
|
Akoya Biosciences |
Illumina Wed | 13:30-14:15 |
QIAGEN |
Olink |
NVision Imaging Technologies Wed | 14:30-15:15 |
Oxford Nanopore Technologies |
Six 15-minute industry spotlights will also take place within the exhibition hall during the coffee breaks and poster sessions:
Stilla Technologies | Monday 16 June, 18:45-19:00
'Setting the stage for microRNA signatures in clinical practice – multiplexed microRNA analysis with digital PCR'
Jorg Tost, France
Agilent | Monday 16 June, 19:15-19:30
'Powering Breakthroughs in Cancer and Immunotherapy with Agilent Integrated Technologies'
Stefano Gabriele, Italy
Cell Signaling Technology | Tuesday 17 June, 11:15-11:30
'Empowering Cancer Research with Award-Winning Technologies from CST: SignalStar® Multiplex IHC and InTraSeqTM Single Cell Analysis'
Maxime Jacquet, Netherlands
Parse Biosciences | Tuesday 17 June, 17:15-17:30
'Redefining Single Cell RNA Sequencing Limits with Evercode Combinatorial Barcoding'
Danniela Scocchia, Spain
TECAN | Wednesday 18 June, 11:15-11:30
'Label-free spheroids and organoids analysis for assays development'
Nicola Vettore, Germany
Cellecta | Wednesday 18 June, 17:15-17:30
'TCR/BCR Repertoire Profiling and other Approaches for Drug Target and Biomarker Discovery'
Alex Chenchik, United States
The EACR is a registered charity in England and Wales (1171827) and a company limited by guarantee (07682372). VAT number: 152897084. Registered address: Sir Colin Campbell Building, University of Nottingham Innovation Park, Triumph Road, Nottingham, NG72TU, UK.
Home | Privacy Policy & Cookies | Site map | Admin
© 2025 EACR2025. All rights reserved.